Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome-Reference-Cited by-同舟云学术

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome

Published:2017-01 Issue:1 Volume:8 Page:1-10
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Dekker Alain D.¹²,Fortea Juan³⁴,Blesa Rafael³,De Deyn Peter P.¹²

Affiliation:

1. Department of Neurology and Alzheimer Research CenterUniversity of Groningen, University Medical Center GroningenGroningenThe Netherlands

2. Laboratory of Neurochemistry and Behaviour, Institute Born‐Bunge, University of AntwerpAntwerpBelgium

3. Department of NeurologyHospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de BarcelonaBarcelonaSpain

4. Down Medical Center, Catalan Down Syndrome FoundationBarcelonaSpain

Funder

Gratama Stichting

Alzheimer Research Center of the University Medical Center Groningen

Research School for Behavioural and Cognitive Neurosciences of the University of Groningen

Stichting Groninger Universiteitsfonds

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2017.02.006

Reference63 articles.

1. Dementia in Down's syndrome

2. The four ages of Down syndrome

3. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

4. 2016 Alzheimer's disease facts and figures;Alzheimer's Assocation;Alzheimers Dement,2016

5. Comparative survival advantage of males with down syndrome

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Specific Serum Markers for Early Prediction of Alzheimer's Disease in Adolescents with Down Syndrome;Indian Journal of Clinical Biochemistry;2024-04-02

2. From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

3. Biomarkers of Cognitive Decline and Dementia in Down Syndrome;Biomarkers in Neuropsychiatry;2023

4. Cognitive outcome measures for tracking Alzheimer's disease in Down syndrome;Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders;2022

5. Fluid biomarkers for Alzheimer's disease in Down syndrome: Current status and novel trends;The Neurobiology of Aging and Alzheimer Disease in Down Syndrome;2022